Conmed (CNMD) Non-cash Items (2019 - 2020)
Conmed posted quarterly Non-cash Items of -$4.0 million for Q4 2020, down 115.4% year-on-year from $25.9 million in Q1 2020, and down 114.13% on a QoQ basis from $28.3 million in Q3 2020.
Conmed (CNMD) has 2 years of Non-cash Items data on file, last reported at -$4.0 million in Q4 2020.
- For the quarter ending Q4 2020, Non-cash Items fell 115.4% year-over-year to -$4.0 million; the trailing twelve-month figure through Dec 2020 stood at $55.0 million (down 17.29% YoY), and the FY2020 full-year result was $55.0 million, down 17.29% from the prior year.
- Non-cash Items for Q4 2020 stood at -$4.0 million, down from $28.3 million in the prior quarter.
- Across five years, Non-cash Items topped out at $32.9 million in Q2 2020 and bottomed at -$4.9 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -4.00 Mn |
| Dec 31, 2020 | -4.00 Mn |
| Sep 30, 2020 | 28.28 Mn |
| Sep 30, 2020 | 28.28 Mn |
| Jun 30, 2020 | 32.94 Mn |
| Jun 30, 2020 | 32.94 Mn |
| Mar 31, 2020 | -2.21 Mn |
| Mar 31, 2020 | -2.21 Mn |
| Dec 31, 2019 | 25.94 Mn |
| Dec 31, 2019 | 25.94 Mn |
| Sep 30, 2019 | 29.63 Mn |
| Sep 30, 2019 | 29.63 Mn |
| Jun 30, 2019 | 15.88 Mn |
| Jun 30, 2019 | 15.88 Mn |
| Mar 31, 2019 | -4.94 Mn |
| Mar 31, 2019 | -4.94 Mn |